Authors:
Ding, X
Mizokami, M
Yao, GB
Xu, B
Orito, E
Ueda, R
Nakanishi, M
Citation: X. Ding et al., Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China, INTERVIROLO, 44(1), 2001, pp. 43-47
Authors:
Yao, GB
Fu, XX
Tian, GS
Xu, DZ
Hao, LJ
Huangfu, YS
Su, CX
Citation: Gb. Yao et al., A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection, J GASTR HEP, 15(10), 2000, pp. 1165-1170
Citation: Gz. Fei et al., Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-alpha therapy in patients with chronic hepatitis B, J VIRAL HEP, 6(3), 1999, pp. 219-227
Citation: Gb. Yao et al., A randomized double-blind placebo-controlled study of lamivudine in the treatment of patients with chronic hepatitis B virus infection, CHIN MED J, 112(5), 1999, pp. 387-391
Authors:
Yao, GB
Ji, YY
Xu, DZ
Gao, J
Wu, XH
Zhang, QB
Hu, DC
Citation: Gb. Yao et al., Long-term efficacy of recombinant interferon alpha 2a in the treatment of chronic hepatitis C: A randomized prospective study comparing two dose schedules in Chinese patients, HEP-GASTRO, 46(26), 1999, pp. 1059-1064